The featured speakers will discuss tested methodology and real-life case studies, as well as the immediate and longer-term benefits of moving to the OPTEL serialization platform.
TORONTO (PRWEB) August 15, 2019
Serialization deadlines in the US and European Union have finally passed. Now what? As serialization mandates become increasingly complex, and aggregation becomes fully applied in the United States in 2023, pharmaceutical companies are scrutinizing whether their current serialization software is the best long-term solution.
Until now, most regulations―including the Drug Supply Chain Security Act (DSCSA)―have required minimal system capabilities. In the coming months, serialization systems will be tested for their ability to handle aggregation data, facilitate integration with distribution (internal and third-party logistics providers), integrate with downstream customers and handle complicated regulatory reporting requirements, such as the European Union’s Falsified Medicines Directive (EU FMD) and the Russian Federal Law No. 425-FZ.
Many players in the pharmaceutical industry have been feeling the pain of serialization solutions that are falling short. With the largest packaging-line installation base of any vendor, OPTEL often hears about these struggles: over-promised and under-delivered capabilities; high rates of issues and bugs; and the unexpected need to pay for costly “optional” tools and third-party resources to maintain a validated, high-performing solution.
Join Ron Watkins, Product Owner at Visit OPTEL and Bill Romano, Sales and Account Executive at OPTEL in a live session on Wednesday, September 11, 2019 at 9am EDT (2pm BST/UK) to better understand serialization options for global requirements. The featured speakers will discuss tested methodology and real-life case studies, as well as the immediate and longer-term benefits of moving to the OPTEL serialization platform.
For more information or to register for this free event, visit Understand Your Serialization Options and the Long and Short-term Benefit of Switching Providers.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Tel: +1 (416) 977-6555 ext 400